nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Anaphylactic shock—Hydrocortisone—psoriasis	0.000422	0.000422	CcSEcCtD
Tobramycin—Asthenia—Mycophenolic acid—psoriasis	0.000421	0.000421	CcSEcCtD
Tobramycin—Nausea—Hydroxyurea—psoriasis	0.000416	0.000416	CcSEcCtD
Tobramycin—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000416	0.000416	CcSEcCtD
Tobramycin—Pruritus—Mycophenolic acid—psoriasis	0.000415	0.000415	CcSEcCtD
Tobramycin—Myalgia—Triamcinolone—psoriasis	0.000414	0.000414	CcSEcCtD
Tobramycin—Nervous system disorder—Hydrocortisone—psoriasis	0.000414	0.000414	CcSEcCtD
Tobramycin—Eye disorder—Prednisone—psoriasis	0.000413	0.000413	CcSEcCtD
Tobramycin—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000413	0.000413	CcSEcCtD
Tobramycin—Decreased appetite—Cyclosporine—psoriasis	0.000413	0.000413	CcSEcCtD
Tobramycin—Infestation NOS—Methotrexate—psoriasis	0.000411	0.000411	CcSEcCtD
Tobramycin—Infestation—Methotrexate—psoriasis	0.000411	0.000411	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.00041	0.00041	CcSEcCtD
Tobramycin—Skin disorder—Hydrocortisone—psoriasis	0.00041	0.00041	CcSEcCtD
Tobramycin—Ill-defined disorder—Betamethasone—psoriasis	0.00041	0.00041	CcSEcCtD
Tobramycin—Ill-defined disorder—Dexamethasone—psoriasis	0.00041	0.00041	CcSEcCtD
Tobramycin—Discomfort—Triamcinolone—psoriasis	0.000409	0.000409	CcSEcCtD
Tobramycin—Pain—Cyclosporine—psoriasis	0.000406	0.000406	CcSEcCtD
Tobramycin—Renal failure—Methotrexate—psoriasis	0.000404	0.000404	CcSEcCtD
Tobramycin—Angioedema—Betamethasone—psoriasis	0.000403	0.000403	CcSEcCtD
Tobramycin—Angioedema—Dexamethasone—psoriasis	0.000403	0.000403	CcSEcCtD
Tobramycin—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000403	0.000403	CcSEcCtD
Tobramycin—Anorexia—Hydrocortisone—psoriasis	0.000402	0.000402	CcSEcCtD
Tobramycin—Diarrhoea—Mycophenolic acid—psoriasis	0.000401	0.000401	CcSEcCtD
Tobramycin—Stomatitis—Methotrexate—psoriasis	0.000401	0.000401	CcSEcCtD
Tobramycin—Angiopathy—Prednisone—psoriasis	0.000401	0.000401	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.0004	0.0004	CcSEcCtD
Tobramycin—Immune system disorder—Prednisone—psoriasis	0.000399	0.000399	CcSEcCtD
Tobramycin—Malaise—Dexamethasone—psoriasis	0.000398	0.000398	CcSEcCtD
Tobramycin—Malaise—Betamethasone—psoriasis	0.000398	0.000398	CcSEcCtD
Tobramycin—Anaphylactic shock—Triamcinolone—psoriasis	0.000397	0.000397	CcSEcCtD
Tobramycin—Vertigo—Dexamethasone—psoriasis	0.000397	0.000397	CcSEcCtD
Tobramycin—Vertigo—Betamethasone—psoriasis	0.000397	0.000397	CcSEcCtD
Tobramycin—Pain—Mycophenolate mofetil—psoriasis	0.000396	0.000396	CcSEcCtD
Tobramycin—Feeling abnormal—Cyclosporine—psoriasis	0.000391	0.000391	CcSEcCtD
Tobramycin—Gastrointestinal pain—Cyclosporine—psoriasis	0.000388	0.000388	CcSEcCtD
Tobramycin—Dizziness—Mycophenolic acid—psoriasis	0.000388	0.000388	CcSEcCtD
Tobramycin—Epistaxis—Methotrexate—psoriasis	0.000388	0.000388	CcSEcCtD
Tobramycin—Paraesthesia—Prednisolone—psoriasis	0.000388	0.000388	CcSEcCtD
Tobramycin—Erythema—Prednisone—psoriasis	0.000385	0.000385	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000384	0.000384	CcSEcCtD
Tobramycin—Agranulocytosis—Methotrexate—psoriasis	0.000384	0.000384	CcSEcCtD
Tobramycin—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000382	0.000382	CcSEcCtD
Tobramycin—Paraesthesia—Hydrocortisone—psoriasis	0.000379	0.000379	CcSEcCtD
Tobramycin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000379	0.000379	CcSEcCtD
Tobramycin—Urticaria—Cyclosporine—psoriasis	0.000377	0.000377	CcSEcCtD
Tobramycin—Myalgia—Dexamethasone—psoriasis	0.000376	0.000376	CcSEcCtD
Tobramycin—Myalgia—Betamethasone—psoriasis	0.000376	0.000376	CcSEcCtD
Tobramycin—Abdominal pain—Cyclosporine—psoriasis	0.000375	0.000375	CcSEcCtD
Tobramycin—Body temperature increased—Cyclosporine—psoriasis	0.000375	0.000375	CcSEcCtD
Tobramycin—Vomiting—Mycophenolic acid—psoriasis	0.000373	0.000373	CcSEcCtD
Tobramycin—Discomfort—Betamethasone—psoriasis	0.000371	0.000371	CcSEcCtD
Tobramycin—Discomfort—Dexamethasone—psoriasis	0.000371	0.000371	CcSEcCtD
Tobramycin—Rash—Mycophenolic acid—psoriasis	0.00037	0.00037	CcSEcCtD
Tobramycin—Dermatitis—Mycophenolic acid—psoriasis	0.00037	0.00037	CcSEcCtD
Tobramycin—Pain—Prednisolone—psoriasis	0.000369	0.000369	CcSEcCtD
Tobramycin—Urticaria—Mycophenolate mofetil—psoriasis	0.000368	0.000368	CcSEcCtD
Tobramycin—Headache—Mycophenolic acid—psoriasis	0.000368	0.000368	CcSEcCtD
Tobramycin—Decreased appetite—Hydrocortisone—psoriasis	0.000367	0.000367	CcSEcCtD
Tobramycin—Pharyngitis—Methotrexate—psoriasis	0.000366	0.000366	CcSEcCtD
Tobramycin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000366	0.000366	CcSEcCtD
Tobramycin—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000366	0.000366	CcSEcCtD
Tobramycin—Urinary tract disorder—Methotrexate—psoriasis	0.000365	0.000365	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000364	0.000364	CcSEcCtD
Tobramycin—Vision blurred—Prednisone—psoriasis	0.000362	0.000362	CcSEcCtD
Tobramycin—Urethral disorder—Methotrexate—psoriasis	0.000362	0.000362	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000362	0.000362	CcSEcCtD
Tobramycin—Pain—Hydrocortisone—psoriasis	0.000361	0.000361	CcSEcCtD
Tobramycin—Anaphylactic shock—Dexamethasone—psoriasis	0.00036	0.00036	CcSEcCtD
Tobramycin—Anaphylactic shock—Betamethasone—psoriasis	0.00036	0.00036	CcSEcCtD
Tobramycin—Ill-defined disorder—Prednisone—psoriasis	0.000357	0.000357	CcSEcCtD
Tobramycin—Paraesthesia—Triamcinolone—psoriasis	0.000357	0.000357	CcSEcCtD
Tobramycin—Feeling abnormal—Prednisolone—psoriasis	0.000356	0.000356	CcSEcCtD
Tobramycin—Visual impairment—Methotrexate—psoriasis	0.000356	0.000356	CcSEcCtD
Tobramycin—Anaemia—Prednisone—psoriasis	0.000355	0.000355	CcSEcCtD
Tobramycin—Dyspnoea—Triamcinolone—psoriasis	0.000354	0.000354	CcSEcCtD
Tobramycin—Nervous system disorder—Betamethasone—psoriasis	0.000353	0.000353	CcSEcCtD
Tobramycin—Nervous system disorder—Dexamethasone—psoriasis	0.000353	0.000353	CcSEcCtD
Tobramycin—Thrombocytopenia—Betamethasone—psoriasis	0.000353	0.000353	CcSEcCtD
Tobramycin—Thrombocytopenia—Dexamethasone—psoriasis	0.000353	0.000353	CcSEcCtD
Tobramycin—Angioedema—Prednisone—psoriasis	0.000351	0.000351	CcSEcCtD
Tobramycin—Hypersensitivity—Cyclosporine—psoriasis	0.00035	0.00035	CcSEcCtD
Tobramycin—Nausea—Mycophenolic acid—psoriasis	0.000348	0.000348	CcSEcCtD
Tobramycin—Feeling abnormal—Hydrocortisone—psoriasis	0.000348	0.000348	CcSEcCtD
Tobramycin—Malaise—Prednisone—psoriasis	0.000347	0.000347	CcSEcCtD
Tobramycin—Vertigo—Prednisone—psoriasis	0.000346	0.000346	CcSEcCtD
Tobramycin—Eye disorder—Methotrexate—psoriasis	0.000345	0.000345	CcSEcCtD
Tobramycin—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000345	0.000345	CcSEcCtD
Tobramycin—Tinnitus—Methotrexate—psoriasis	0.000344	0.000344	CcSEcCtD
Tobramycin—Anorexia—Betamethasone—psoriasis	0.000344	0.000344	CcSEcCtD
Tobramycin—Anorexia—Dexamethasone—psoriasis	0.000344	0.000344	CcSEcCtD
Tobramycin—Urticaria—Prednisolone—psoriasis	0.000343	0.000343	CcSEcCtD
Tobramycin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000341	0.000341	CcSEcCtD
Tobramycin—Asthenia—Cyclosporine—psoriasis	0.000341	0.000341	CcSEcCtD
Tobramycin—Pain—Triamcinolone—psoriasis	0.00034	0.00034	CcSEcCtD
Tobramycin—Pruritus—Cyclosporine—psoriasis	0.000336	0.000336	CcSEcCtD
Tobramycin—Urticaria—Hydrocortisone—psoriasis	0.000335	0.000335	CcSEcCtD
Tobramycin—Angiopathy—Methotrexate—psoriasis	0.000335	0.000335	CcSEcCtD
Tobramycin—Immune system disorder—Methotrexate—psoriasis	0.000333	0.000333	CcSEcCtD
Tobramycin—Abdominal pain—Hydrocortisone—psoriasis	0.000333	0.000333	CcSEcCtD
Tobramycin—Body temperature increased—Hydrocortisone—psoriasis	0.000333	0.000333	CcSEcCtD
Tobramycin—Mediastinal disorder—Methotrexate—psoriasis	0.000333	0.000333	CcSEcCtD
Tobramycin—Asthenia—Mycophenolate mofetil—psoriasis	0.000332	0.000332	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000328	0.000328	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000328	0.000328	CcSEcCtD
Tobramycin—Pruritus—Mycophenolate mofetil—psoriasis	0.000328	0.000328	CcSEcCtD
Tobramycin—Myalgia—Prednisone—psoriasis	0.000327	0.000327	CcSEcCtD
Tobramycin—Feeling abnormal—Triamcinolone—psoriasis	0.000327	0.000327	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000325	0.000325	CcSEcCtD
Tobramycin—Diarrhoea—Cyclosporine—psoriasis	0.000325	0.000325	CcSEcCtD
Tobramycin—Paraesthesia—Betamethasone—psoriasis	0.000324	0.000324	CcSEcCtD
Tobramycin—Paraesthesia—Dexamethasone—psoriasis	0.000324	0.000324	CcSEcCtD
Tobramycin—Discomfort—Prednisone—psoriasis	0.000323	0.000323	CcSEcCtD
Tobramycin—Erythema—Methotrexate—psoriasis	0.000321	0.000321	CcSEcCtD
Tobramycin—Hypersensitivity—Prednisolone—psoriasis	0.000318	0.000318	CcSEcCtD
Tobramycin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000317	0.000317	CcSEcCtD
Tobramycin—Urticaria—Triamcinolone—psoriasis	0.000316	0.000316	CcSEcCtD
Tobramycin—Dysgeusia—Methotrexate—psoriasis	0.000315	0.000315	CcSEcCtD
Tobramycin—Body temperature increased—Triamcinolone—psoriasis	0.000314	0.000314	CcSEcCtD
Tobramycin—Dizziness—Cyclosporine—psoriasis	0.000314	0.000314	CcSEcCtD
Tobramycin—Anaphylactic shock—Prednisone—psoriasis	0.000314	0.000314	CcSEcCtD
Tobramycin—Decreased appetite—Dexamethasone—psoriasis	0.000313	0.000313	CcSEcCtD
Tobramycin—Decreased appetite—Betamethasone—psoriasis	0.000313	0.000313	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000311	0.000311	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000311	0.000311	CcSEcCtD
Tobramycin—Back pain—Methotrexate—psoriasis	0.000311	0.000311	CcSEcCtD
Tobramycin—Hypersensitivity—Hydrocortisone—psoriasis	0.000311	0.000311	CcSEcCtD
Tobramycin—Pain—Dexamethasone—psoriasis	0.000308	0.000308	CcSEcCtD
Tobramycin—Pain—Betamethasone—psoriasis	0.000308	0.000308	CcSEcCtD
Tobramycin—Nervous system disorder—Prednisone—psoriasis	0.000308	0.000308	CcSEcCtD
Tobramycin—Dizziness—Mycophenolate mofetil—psoriasis	0.000306	0.000306	CcSEcCtD
Tobramycin—Skin disorder—Prednisone—psoriasis	0.000305	0.000305	CcSEcCtD
Tobramycin—Vision blurred—Methotrexate—psoriasis	0.000303	0.000303	CcSEcCtD
Tobramycin—Asthenia—Hydrocortisone—psoriasis	0.000303	0.000303	CcSEcCtD
Tobramycin—Vomiting—Cyclosporine—psoriasis	0.000302	0.000302	CcSEcCtD
Tobramycin—Rash—Cyclosporine—psoriasis	0.000299	0.000299	CcSEcCtD
Tobramycin—Anorexia—Prednisone—psoriasis	0.000299	0.000299	CcSEcCtD
Tobramycin—Dermatitis—Cyclosporine—psoriasis	0.000299	0.000299	CcSEcCtD
Tobramycin—Pruritus—Hydrocortisone—psoriasis	0.000298	0.000298	CcSEcCtD
Tobramycin—Ill-defined disorder—Methotrexate—psoriasis	0.000298	0.000298	CcSEcCtD
Tobramycin—Headache—Cyclosporine—psoriasis	0.000297	0.000297	CcSEcCtD
Tobramycin—Anaemia—Methotrexate—psoriasis	0.000297	0.000297	CcSEcCtD
Tobramycin—Feeling abnormal—Dexamethasone—psoriasis	0.000297	0.000297	CcSEcCtD
Tobramycin—Feeling abnormal—Betamethasone—psoriasis	0.000297	0.000297	CcSEcCtD
Tobramycin—Gastrointestinal pain—Dexamethasone—psoriasis	0.000295	0.000295	CcSEcCtD
Tobramycin—Gastrointestinal pain—Betamethasone—psoriasis	0.000295	0.000295	CcSEcCtD
Tobramycin—Vomiting—Mycophenolate mofetil—psoriasis	0.000294	0.000294	CcSEcCtD
Tobramycin—Hypersensitivity—Triamcinolone—psoriasis	0.000293	0.000293	CcSEcCtD
Tobramycin—Rash—Mycophenolate mofetil—psoriasis	0.000292	0.000292	CcSEcCtD
Tobramycin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000292	0.000292	CcSEcCtD
Tobramycin—Headache—Mycophenolate mofetil—psoriasis	0.00029	0.00029	CcSEcCtD
Tobramycin—Malaise—Methotrexate—psoriasis	0.00029	0.00029	CcSEcCtD
Tobramycin—Vertigo—Methotrexate—psoriasis	0.000289	0.000289	CcSEcCtD
Tobramycin—Diarrhoea—Hydrocortisone—psoriasis	0.000289	0.000289	CcSEcCtD
Tobramycin—Leukopenia—Methotrexate—psoriasis	0.000288	0.000288	CcSEcCtD
Tobramycin—Urticaria—Dexamethasone—psoriasis	0.000286	0.000286	CcSEcCtD
Tobramycin—Urticaria—Betamethasone—psoriasis	0.000286	0.000286	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000286	0.000286	CcSEcCtD
Tobramycin—Dizziness—Prednisolone—psoriasis	0.000286	0.000286	CcSEcCtD
Tobramycin—Asthenia—Triamcinolone—psoriasis	0.000285	0.000285	CcSEcCtD
Tobramycin—Abdominal pain—Betamethasone—psoriasis	0.000285	0.000285	CcSEcCtD
Tobramycin—Abdominal pain—Dexamethasone—psoriasis	0.000285	0.000285	CcSEcCtD
Tobramycin—Body temperature increased—Betamethasone—psoriasis	0.000285	0.000285	CcSEcCtD
Tobramycin—Body temperature increased—Dexamethasone—psoriasis	0.000285	0.000285	CcSEcCtD
Tobramycin—Nausea—Cyclosporine—psoriasis	0.000282	0.000282	CcSEcCtD
Tobramycin—Paraesthesia—Prednisone—psoriasis	0.000282	0.000282	CcSEcCtD
Tobramycin—Pruritus—Triamcinolone—psoriasis	0.000281	0.000281	CcSEcCtD
Tobramycin—Cough—Methotrexate—psoriasis	0.00028	0.00028	CcSEcCtD
Tobramycin—Dizziness—Hydrocortisone—psoriasis	0.000279	0.000279	CcSEcCtD
Tobramycin—Nausea—Mycophenolate mofetil—psoriasis	0.000275	0.000275	CcSEcCtD
Tobramycin—Myalgia—Methotrexate—psoriasis	0.000274	0.000274	CcSEcCtD
Tobramycin—Chest pain—Methotrexate—psoriasis	0.000274	0.000274	CcSEcCtD
Tobramycin—Decreased appetite—Prednisone—psoriasis	0.000273	0.000273	CcSEcCtD
Tobramycin—Rash—Prednisolone—psoriasis	0.000272	0.000272	CcSEcCtD
Tobramycin—Dermatitis—Prednisolone—psoriasis	0.000272	0.000272	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000272	0.000272	CcSEcCtD
Tobramycin—Headache—Prednisolone—psoriasis	0.000271	0.000271	CcSEcCtD
Tobramycin—Discomfort—Methotrexate—psoriasis	0.00027	0.00027	CcSEcCtD
Tobramycin—Vomiting—Hydrocortisone—psoriasis	0.000268	0.000268	CcSEcCtD
Tobramycin—Rash—Hydrocortisone—psoriasis	0.000266	0.000266	CcSEcCtD
Tobramycin—Dermatitis—Hydrocortisone—psoriasis	0.000266	0.000266	CcSEcCtD
Tobramycin—Confusional state—Methotrexate—psoriasis	0.000264	0.000264	CcSEcCtD
Tobramycin—Headache—Hydrocortisone—psoriasis	0.000264	0.000264	CcSEcCtD
Tobramycin—Dizziness—Triamcinolone—psoriasis	0.000263	0.000263	CcSEcCtD
Tobramycin—Anaphylactic shock—Methotrexate—psoriasis	0.000262	0.000262	CcSEcCtD
Tobramycin—Feeling abnormal—Prednisone—psoriasis	0.000259	0.000259	CcSEcCtD
Tobramycin—Asthenia—Betamethasone—psoriasis	0.000259	0.000259	CcSEcCtD
Tobramycin—Asthenia—Dexamethasone—psoriasis	0.000259	0.000259	CcSEcCtD
Tobramycin—Nervous system disorder—Methotrexate—psoriasis	0.000257	0.000257	CcSEcCtD
Tobramycin—Thrombocytopenia—Methotrexate—psoriasis	0.000257	0.000257	CcSEcCtD
Tobramycin—Gastrointestinal pain—Prednisone—psoriasis	0.000257	0.000257	CcSEcCtD
Tobramycin—Nausea—Prednisolone—psoriasis	0.000257	0.000257	CcSEcCtD
Tobramycin—Pruritus—Betamethasone—psoriasis	0.000255	0.000255	CcSEcCtD
Tobramycin—Pruritus—Dexamethasone—psoriasis	0.000255	0.000255	CcSEcCtD
Tobramycin—Skin disorder—Methotrexate—psoriasis	0.000255	0.000255	CcSEcCtD
Tobramycin—Vomiting—Triamcinolone—psoriasis	0.000253	0.000253	CcSEcCtD
Tobramycin—Nausea—Hydrocortisone—psoriasis	0.000251	0.000251	CcSEcCtD
Tobramycin—Rash—Triamcinolone—psoriasis	0.00025	0.00025	CcSEcCtD
Tobramycin—Dermatitis—Triamcinolone—psoriasis	0.00025	0.00025	CcSEcCtD
Tobramycin—Anorexia—Methotrexate—psoriasis	0.00025	0.00025	CcSEcCtD
Tobramycin—Urticaria—Prednisone—psoriasis	0.000249	0.000249	CcSEcCtD
Tobramycin—Headache—Triamcinolone—psoriasis	0.000249	0.000249	CcSEcCtD
Tobramycin—Abdominal pain—Prednisone—psoriasis	0.000248	0.000248	CcSEcCtD
Tobramycin—Body temperature increased—Prednisone—psoriasis	0.000248	0.000248	CcSEcCtD
Tobramycin—Diarrhoea—Dexamethasone—psoriasis	0.000247	0.000247	CcSEcCtD
Tobramycin—Diarrhoea—Betamethasone—psoriasis	0.000247	0.000247	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000239	0.000239	CcSEcCtD
Tobramycin—Dizziness—Dexamethasone—psoriasis	0.000238	0.000238	CcSEcCtD
Tobramycin—Dizziness—Betamethasone—psoriasis	0.000238	0.000238	CcSEcCtD
Tobramycin—Nausea—Triamcinolone—psoriasis	0.000236	0.000236	CcSEcCtD
Tobramycin—Paraesthesia—Methotrexate—psoriasis	0.000236	0.000236	CcSEcCtD
Tobramycin—Dyspnoea—Methotrexate—psoriasis	0.000234	0.000234	CcSEcCtD
Tobramycin—Hypersensitivity—Prednisone—psoriasis	0.000231	0.000231	CcSEcCtD
Tobramycin—Vomiting—Betamethasone—psoriasis	0.000229	0.000229	CcSEcCtD
Tobramycin—Vomiting—Dexamethasone—psoriasis	0.000229	0.000229	CcSEcCtD
Tobramycin—Decreased appetite—Methotrexate—psoriasis	0.000228	0.000228	CcSEcCtD
Tobramycin—Rash—Betamethasone—psoriasis	0.000227	0.000227	CcSEcCtD
Tobramycin—Rash—Dexamethasone—psoriasis	0.000227	0.000227	CcSEcCtD
Tobramycin—Dermatitis—Betamethasone—psoriasis	0.000227	0.000227	CcSEcCtD
Tobramycin—Dermatitis—Dexamethasone—psoriasis	0.000227	0.000227	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Methotrexate—psoriasis	0.000226	0.000226	CcSEcCtD
Tobramycin—Headache—Dexamethasone—psoriasis	0.000226	0.000226	CcSEcCtD
Tobramycin—Headache—Betamethasone—psoriasis	0.000226	0.000226	CcSEcCtD
Tobramycin—Asthenia—Prednisone—psoriasis	0.000225	0.000225	CcSEcCtD
Tobramycin—Pain—Methotrexate—psoriasis	0.000224	0.000224	CcSEcCtD
Tobramycin—Pruritus—Prednisone—psoriasis	0.000222	0.000222	CcSEcCtD
Tobramycin—Feeling abnormal—Methotrexate—psoriasis	0.000216	0.000216	CcSEcCtD
Tobramycin—Diarrhoea—Prednisone—psoriasis	0.000215	0.000215	CcSEcCtD
Tobramycin—Gastrointestinal pain—Methotrexate—psoriasis	0.000214	0.000214	CcSEcCtD
Tobramycin—Nausea—Betamethasone—psoriasis	0.000214	0.000214	CcSEcCtD
Tobramycin—Nausea—Dexamethasone—psoriasis	0.000214	0.000214	CcSEcCtD
Tobramycin—Urticaria—Methotrexate—psoriasis	0.000208	0.000208	CcSEcCtD
Tobramycin—Dizziness—Prednisone—psoriasis	0.000208	0.000208	CcSEcCtD
Tobramycin—Abdominal pain—Methotrexate—psoriasis	0.000207	0.000207	CcSEcCtD
Tobramycin—Body temperature increased—Methotrexate—psoriasis	0.000207	0.000207	CcSEcCtD
Tobramycin—Vomiting—Prednisone—psoriasis	0.0002	0.0002	CcSEcCtD
Tobramycin—Rash—Prednisone—psoriasis	0.000198	0.000198	CcSEcCtD
Tobramycin—Dermatitis—Prednisone—psoriasis	0.000198	0.000198	CcSEcCtD
Tobramycin—Headache—Prednisone—psoriasis	0.000197	0.000197	CcSEcCtD
Tobramycin—Hypersensitivity—Methotrexate—psoriasis	0.000193	0.000193	CcSEcCtD
Tobramycin—Asthenia—Methotrexate—psoriasis	0.000188	0.000188	CcSEcCtD
Tobramycin—Nausea—Prednisone—psoriasis	0.000186	0.000186	CcSEcCtD
Tobramycin—Pruritus—Methotrexate—psoriasis	0.000186	0.000186	CcSEcCtD
Tobramycin—Diarrhoea—Methotrexate—psoriasis	0.000179	0.000179	CcSEcCtD
Tobramycin—Dizziness—Methotrexate—psoriasis	0.000173	0.000173	CcSEcCtD
Tobramycin—Vomiting—Methotrexate—psoriasis	0.000167	0.000167	CcSEcCtD
Tobramycin—Rash—Methotrexate—psoriasis	0.000165	0.000165	CcSEcCtD
Tobramycin—Dermatitis—Methotrexate—psoriasis	0.000165	0.000165	CcSEcCtD
Tobramycin—Headache—Methotrexate—psoriasis	0.000164	0.000164	CcSEcCtD
Tobramycin—Nausea—Methotrexate—psoriasis	0.000156	0.000156	CcSEcCtD
